Results 301 to 310 of about 139,619 (346)

Dietary Riboflavin Supplementation Suppresses Colorectal Cancer Progression by Restoring the Function Effector of CD8+ T Cells

Food Frontiers, EarlyView.
Intestinal tumor cells impair CD8+T cell cytotoxicity by upregulating riboflavin uptake, a process reversible with riboflavin supplementation ABSTRACT Tumor cells have a competitive edge in nutrient uptake, leading to immune cell nutrient deprivation within the tumor microenvironment (TME) and suppressing anti‐tumor immunity.
Lining Chen, Yao Lu, Peng Xue, Yingying Lin, Zhen Zhang, Yuqi Wang, Yuning Zhang, Heng Quan, Yiran Wang, Huiyuan Guo   +9 more
wiley   +1 more source

The TIP60-CD44 Axis Modulates Colorectal Cancer Stemness. [PDF]

Cells
Mohammad A, Jha S.
europepmc   +1 more source

Luteolin Nanomedicine with Stimulus-Driven Traceless Release for Targeting Treatment of Atherosclerosis by Enhancing Lipid Efflux. [PDF]

Research (Wash D C)
Chen S, Wang Z, Shen Z, He D, Liu L, Qian L, Ma B, Huang H.   +7 more
europepmc   +1 more source

Glycoprotein NMB mediates bidirectional GSC-TAM interactions to promote tumor progression. [PDF]

JCI Insight
Liu Y, Pang L, Khan F, Wu J, Zhou F, Horbinski C, Bao S, Yu JS, Lathia JD, Chen P.   +9 more
europepmc   +1 more source

Inorganic Arsenite [As (III)] Represses Human Renal Progenitor Cell Characteristics and Induces Neoplastic-like Transformation. [PDF]

Cells
Haque ME, Shrestha S, Sens DA, Garrett SH.   +3 more
europepmc   +1 more source

Impact of CD44/326 peritoneal cells as response indicators in advanced gastric cancer patients receiving repeated intraperitoneal perfusion normothermic chemotherapy. [PDF]

Ther Adv Med Oncol
Filho OS, Rondinelli R, Acetta AC, Bertolace S, Palladino A, Guedes CD, Vieira CCR, Thuler LCS, Diniz C, Dos Santos EC, Abdelhay E.   +10 more
europepmc   +1 more source

Immunomodulatory natural polysaccharide‐based nanoparticles for the treatment of neurodegenerative diseases

Ibrain, EarlyView.
Polysaccharide‐based nanoparticles offer versatile platforms for drug delivery and immune modulation in neurodegenerative diseases. This review highlights their potential in treating Alzheimer's, Parkinson's, and multiple sclerosis, focusing on targeted delivery and neuroinflammation.
Leto‐Aikaterini Tziveleka, Mariafrancesca Cascione, Paolo Pellegrino, Annalisa Bianco, Stefano Leporatti, Valeria De Matteis   +5 more
wiley   +1 more source

Hyaluronan: An Architect and Integrator for Cancer and Neural Diseases. [PDF]

Int J Mol Sci
Hsu CY, Nguyen-Tran HH, Chen YA, Lee KT, Juang TY, Chiang MF, Liu SY, Chang NS.   +7 more
europepmc   +1 more source

Mass cytometric detection of homologous recombination proficiency in circulating tumor cells to predict chemoresistance of metastatic breast cancer patients

International Journal of Cancer, EarlyView.
What's New? Circulating tumor cells can offer insights into treatment responses and metastatic recurrence, but current analysis methods are limited. Here, the authors tested a newly developed mass cytometry panel comprising biomarkers such as γH2AX and RAD51 in longitudinally monitored metastatic breast cancer patients.
Kathrin Niedermayer, Henning Schäffler, Georgios Vlachos, Sara Greco, Kerstin Pfister, Barbara Volz, Leonie Ott, Hans Neubauer, Bernhard Polzer, André Koch, Sabine Riethdorf, Tanja Fehm, Wolfgang Janni, Thomas W. P. Friedl, Brigitte Rack, Ellen Heitzer, Fabienne Schochter, Lisa Wiesmüller   +17 more
wiley   +1 more source

Diagnostic Potential of CD44, CD133, and VDR in Epithelial Ovarian Tumors: Association with Histopathology Parameters. [PDF]

Int J Mol Sci
Jovanović L, Šošić-Jurjević B, Ćirković A, Dragičević S, Filipović B, Milenković S, Dugalić S, Gojnić-Dugalić M, Nikolić A.   +8 more
europepmc   +1 more source